150
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cancer Survival Trends in Southeastern China, 2011–2021: A Population-Based Study

, , ORCID Icon, , , & show all
Pages 45-56 | Received 26 Sep 2023, Accepted 17 Jan 2024, Published online: 31 Jan 2024

References

  • GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–1505. doi:10.1016/S1470-2045(19)30456-5
  • Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Global Health. 2018;6(5):e555–e567. doi:10.1016/S2214-109X(18)30127-X
  • Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (Concord-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
  • Li Y, Yu L, Na J, et al. Survival of cancer patients in Northeast China: analysis of sampled cancers from population-based cancer registries. Cancer Res Treat. 2017;49(4):1106–1113. doi:10.4143/crt.2016.613
  • National bureau of statistics of the People’s Republic of China. Zhonghua renmin gongheguo guojia tongjiju; 2023. Available from: http://www.stats.gov.cn/. Accessed January 11, 2023.
  • Ye Y, Zhong W, Huang S, Li X. Fujian sheng 1990-2010 nian jumin chusheng qiwang shouming [A comparison study on the life expectancy among residents in Fujian province, 1990–2010]. Chin J Epidemiol. 2014;35(3):280–284. Chinese.
  • Wei W, Zeng H, Zheng R, et al. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol. 2020;21(7):e342–e349. doi:10.1016/S1470-2045(20)30073-5
  • Wei K-R, Chen W-Q, Zhang S-W, et al. Cancer registration in the Peoples Republic of China. Asian Pac J Cancer Prev. 2012;13(8):4209–4214.
  • Curado M-P, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents, Volume IX. IARC Press, International Agency for Research on Cancer; 2007.
  • Ederer F, Heise H. Instructions to IBM 650 Programmers in Processing Survival Computations. Bethesda, MD: National Cancer Institute; 1959.
  • Eldandt-Johnson R, Johnson N. Survival Models and Data Analysis (Wiley Series in Probability and Mathematical Statistics). Indianapolis: Wiley; 1980.
  • Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer. 2004;40(16):2494–2501. doi:10.1016/j.ejca.2004.07.022
  • Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40(15):2307–2316. doi:10.1016/j.ejca.2004.07.002
  • Brenner H, Gefeller O, Hakulinen T. A computer program for period analysis of cancer patient survival. Eur J Cancer. 2002;38(5):690–695. doi:10.1016/S0959-8049(02)00003-5
  • Coleman MP. Cancer survival: global surveillance will stimulate health policy and improve equity. Lancet. 2014;383(9916):564–573. doi:10.1016/S0140-6736(13)62225-4
  • Brown S, Castelli M, Hunter DJ, et al. How might healthcare systems influence speed of cancer diagnosis: a narrative review. Soc Sci Med. 2014;116:56–63. doi:10.1016/j.socscimed.2014.06.030
  • Nielsen M. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328(17):1237–1243. doi:10.1056/NEJM199304293281706
  • Li X, Lu J, Hu S, et al. The primary health-care system in China. Lancet. 2017;390(10112):2584–2594. doi:10.1016/S0140-6736(17)33109-4
  • Cai Y, Xue M, Chen W, et al. Expenditure of hospital care on cancer in China, from 2011 to 2015. Chin J Cancer Res. 2017;29(3):253–262. doi:10.21147/j.issn.1000-9604.2017.03.11
  • Xiao-Nong Z, Xiao-Nong Z. Epidemic trend, screening, and early detection and treatment of cancer in Chinese population. Cancer Biol Med. 2017;14(1):50–59. doi:10.20892/j.issn.2095-3941.2016.0047
  • Luo YH, Chiu CH, Kuo C, et al. Lung cancer in Republic of China. J Thorac Oncol. 2021;16(4):519–527. doi:10.1016/j.jtho.2020.10.155
  • Chen P, Liu Y, Wen Y, Zhou C. Non-small cell lung cancer in China. Cancer Commun. 2022;42(10):937–970.
  • Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640–649. doi:10.1056/NEJMoa1916623
  • Jiang F, Fu ZT, Lu ZL, et al. 2012-2018 nian shandong sheng zhongliu dengji diqu aizheng xinfa bingli de shengcun fenxi [Cancer survival during 2012–2018 in cancer registries of Shandong Province]. Chin J Prev Med. 2022;56(6):806–814. Chinese.
  • Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet. 2012;379(9818):805–814. doi:10.1016/S0140-6736(12)60278-5
  • Li D, Zhang J, Yang J, et al. Socio-economic inequalities in health service utilization among Chinese rural migrant workers with new cooperative medical scheme: a multilevel regression approach. BMC Public Health. 2022;22(1):1–14. doi:10.1186/s12889-021-12274-7
  • Zeng C, Wen W, Morgans AK, et al. Disparities by race, age, and sex in the improvement of survival for major cancers: results from the national cancer institute Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1990 to 2010. JAMA Oncol. 2015;1(1):88–96. doi:10.1001/jamaoncol.2014.161
  • Swaminathan R, Rama R, Shanta V. Lack of active follow-up of cancer patients in Chennai, India: implications for population-based survival estimates. Bull World Health Organ. 2008;86(7):509–515. doi:10.2471/BLT.07.046979